Business Wire

Foundever ® and Cognigy Strengthen Strategic Partnership to Deliver Scalable Agentic AI Solutions Across the Globe

Share

Foundever®, a global leader in the customer experience (CX) industry, today announced an expansion of its long-term collaboration with Cognigy, a global leader in AI-powered customer service solutions, in bringing Agentic AI into full-scale production across enterprise CX environments. This partnership addresses the increasing demand from global brands for sophisticated AI solutions that offer proactive, autonomous service, going beyond basic automation to deliver secure, scalable, personalized and human-centric interactions.

By integrating the large-scale and global operational capabilities of Foundever with Cognigy's powerful Agentic AI, this partnership redefines the possibilities of automation, exceeding the limitations of traditional chatbots. In a truly Agentic CX environment, Foundever ensures AI agents work seamlessly alongside humans to create a real, integrated experience across diverse customer journeys. With conversational design built on a depth of experience managing over 3.3 billion customer interactions each year, Foundever brings operational processes and training to empower both AI and human agents. Using data to drive continuous improvements across all aspects of the customer experience, the combined capabilities of Foundever and Cognigy connect data, technology and human expertise in ways that deliver unmatched value.

As organizations rush to incorporate AI, the truth is clear: simply showcasing impressive demos is not enough. Together, Foundever and Cognigy are bridging this gap while accelerating the transition of AI-powered CX into real-world applications, demonstrating tangible, measurable results. The proactive approach and strategic insight that Foundever brings into operationalizing AI technology highlights its role as both a beneficiary and a creator of substantial value. This partnership, already trusted by Fortune 500 brands worldwide, paves the way from innovative ideas to widespread enterprise implementation.

“At Foundever, we are dedicated to delivering solutions that provide real value at scale,” stated Laurent Uberti, President, CEO & Founder of Foundever. “Our collaboration with Cognigy is centered around deploying Agentic AI that operates effectively in production, at scale, and across various channels. Together, we’re establishing a new standard for what AI can achieve in customer interactions—enhancing CX while driving significant operational efficiencies. Our clients can expect not just advanced technology but also improved customer satisfaction, reduced operational costs and the ability to respond faster to market changes.”

As part of this partnership, Cognigy’s platform will integrate into the global CX operations of Foundever, enabling the deployment of multilingual, autonomous AI agents across both voice and digital channels. Built for adaptability, security and scalability, Cognigy empowers organizations to move beyond trial phases and embark on impactful, measurable transformations that yield substantial returns on investment. This expanded partnership is about delivering solutions that result in faster response times and improved customer engagement, ultimately driving growth for clients of Foundever and Cognigy.

“This expanded partnership with Foundever marks a pivotal step in bringing Agentic AI into real-world CX at scale,” said Philipp Heltewig, CEO and Co-founder at Cognigy. “We’ve already seen the value of combining Foundever’s global CX delivery with Cognigy’s AI Agent platform — and now we’re accelerating that impact. Together, we’re proving that AI Agents can do more than just automate — they can transform the way enterprises serve customers across channels, languages, and geographies.”

The partnership’s continued success was recognized at Nexus 2025, Cognigy’s flagship AI summit, where Foundever received the Most Unique Use Case award in the Innovation Champions category. With over 750 attendees from global brands, the event celebrated companies leveraging Cognigy’s AI Agents to deliver exceptional CX and tangible business impact.

With Foundever and Cognigy leading the charge, the future of AI-driven customer experience is here—powered by intelligent technology and a commitment to innovation. For more information on Foundever and its initiatives, visit foundever.com.

About Foundever

Foundever® is a global leader in the customer experience (CX) industry. With 150,000 associates across the globe, we’re the team behind the best experiences for +800 of the world’s leading and digital-first brands. Our innovative CX solutions, technology and expertise are designed to support operational needs for our clients and deliver a seamless experience to customers in the moments that matter.

Supporting +9 million customer conversations every day in +60 languages across 45 countries, Foundever combines global strength and scale with the agile, entrepreneurial approach of our founder-led culture, enabling companies of all sizes and industries to transform their CX. Sitel Group and SYKES are now Foundever.

Get to know us at www.foundever.com and connect with us on Facebook, LinkedIn and X.

About Cognigy

Cognigy is transforming the customer service industry with the most advanced AI Agent platform for enterprise contact centers. Its award-winning solution, Cognigy.AI, empowers enterprises to deliver instant, hyper-personalized, multilingual service on any channel. By integrating Generative and Conversational AI to create Agentic AI, Cognigy delivers AI Agents that redefine customer experiences, drive satisfaction, and support contact center employees in real-time. Over 1,000 brands worldwide trust Cognigy and its vast partner network to create AI customer service agents for their contact center. Cognigy's impressive worldwide customer portfolio includes Bosch, Nestlé, DHL, Frontier Airlines, Lufthansa Group, Mercedes-Benz and Toyota.

For more information and to book a demo visit: www.cognigy.com. Follow the company on X (formerly Twitter) @Cognigy and on LinkedIn at https://www.linkedin.com/company/cognigy.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250610379651/en/

Contacts

Media contacts
Rebecca Sanders, Foundever
media@foundever.com

Cognigy
Cognigy@avenuez.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle

NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press Release

NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release

Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release

Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye